Carlos D.

Carlos D. is an experienced professional in business development and strategy, currently serving as the Director of Business Development at Ascertain since 2024, where responsibilities include enhancing healthcare organization operations through AI-powered solutions. Previous roles include Advisor at Optain, Strategy and Partnerships at Verily Life Sciences, and New Product Manager/Business Development Director at Baebies, where Carlos marketed diagnostic products to strategic partners. Carlos has also contributed as a Board Member at Ripple Science, overseeing a SaaS solution for clinical trials, and held positions such as Director of Corporate Development at Hyperfine Research, where leadership was provided for a point-of-care MRI product. Earlier in the career, Carlos served as a Strategy Consultant at ClearView Partners and Kudu Management Consulting, and as a Flagship VentureLabs Fellow at Flagship Pioneering, where company concepts were developed and launched. A Ph.D. in Neuroscience from Cornell University, an MBA from MIT Sloan School of Management, and a B.S. in Science from Duke University complement Carlos's extensive expertise in the healthcare and biopharma sectors.